Pharmacol Res Perspect. 2023 Feb;11(1):e01036. doi: 10.1002/prp2.1036.
NO ABSTRACT
PMID:36537346 | DOI:10.1002/prp2.1036
Categories
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19
